Mahamaya Lifesciences Limited
ListedSMEChemicals & Agrochemicals · BSE
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in the manufacturing, registration, and export of high-quality crop protection products and bioproducts designed to enhance soil and crop health. The company specializes in pesticide formulations and supplies bulk products to leading Indian agrochemical players as well as multinational corporations (MNCs). Mahamaya imports global research-based molecules, registers them with the Central Insecticides Board, and markets both technical and value-added formulations. The company has invested significantly in global registrations and currently exports to markets such as the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey. Its portfolio spans bulk formulations, technical grade molecules, branded products, and export-focused formulations.
Price Band
₹108 – ₹114
Issue Size
₹70.44 Cr
Lot Size
1200 shares
GMP
—
Est. Listing
₹114
at current GMP
Subscribed
1.71x
overall
Open
11 Nov 2025
Close
13 Nov 2025
Allotment
14 Nov 2025
Refund
15 Nov 2025
Demat Credit
16 Nov 2025
Listing
18 Nov 2025
Last updated 12 days ago
Overall Subscription
1.71x
Total Demand
QIB Multiplier
1.19x
Institutions & Funds
NII / HNI
3.99x
High Net-Worth
Retail (RII)
1.02x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 1,176,000 | 1,401,600 | 1.19x |
| NIB | 882,000 | 3,514,800 | 3.99x |
| HNIs(10L +) | 588,000 | 3,250,800 | 5.53x |
| HNIs (2-10L) | 294,000 | 264,000 | 0.90x |
| RETAIL | 2,059,200 | 2,107,200 | 1.02x |
| Total | 4,999,200 | 10,538,400 | 1.71x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| QIB | — | 9 | 0.00x |
| NIB | — | 146 | 0.00x |
| RETAIL | 858 | 878 | 1.02x |
| HNIs(10L +) | 163 | 83 | 0.51x |
| HNIs (2-10L) | 82 | 63 | 0.77x |
| Total Applications | 1,103 | 1,179 | 1.07x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Mahamaya Lifesciences Limited Public Issue & Market Profile
Mahamaya Lifesciences Limited is bringing an initial public offering (IPO) in the Chemicals & Agrochemicals sector with an aggregate issue size of ₹70.44 Crores. The shares are offered at a price band of ₹108 to ₹114 per equity share on BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Bidding & Quota Instructions:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Allotment Reconciliation Schedule:
Following the close of bidding on 2025-11-13, the basis of allotment is scheduled to be finalized on 2025-11-14. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Mahamaya Lifesciences Limited IPO GMP today?
Currently, Mahamaya Lifesciences Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹108 to ₹114 per equity share.
What is the expected profit per lot for Mahamaya Lifesciences Limited IPO?
The retail lot size is 1200 shares requiring a minimum application amount of ₹1,36,800. Expected listing price is ₹114 per equity share.
What is the issue size and price band for Mahamaya Lifesciences Limited IPO?
The Mahamaya Lifesciences Limited IPO aggregate issue size is ₹70.44 Crores with an equity price band set at ₹108 to ₹114 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,36,800.
How can I check Mahamaya Lifesciences Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 1.71x (Retail: 1.02x, QIB: 1.19x, NII: 3.99x). You can track live multiples directly on our dedicated subscription page.
Where and when will Mahamaya Lifesciences Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2025-11-14. Investors can verify status using PAN card or application number.
When is the listing date for Mahamaya Lifesciences Limited IPO?
Mahamaya Lifesciences Limited shares are scheduled to list on BSE on 2025-11-18.